Opdivo

Active Ingredient(s): Nivolumab
FDA Approved: * December 22, 2014
Pharm Company: * BRISTOL MYERS SQUIBB
Category: Cancer

Nivolumab, sold under the brand name Opdivo, is a medication used to treat a number of types of cancer.[6] This includes melanoma, lung cancer, malignant pleural mesothelioma, renal cell carcinoma, Hodgkin lymphoma, head and neck cancer, urothelial carcinoma, colon cancer, esophageal squamous cell carcinoma, liver cancer, gastric cancer, and esophageal or gastroesophageal junction (GEJ) cancer.[4][5][6][7][... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
2 Discussions

Dosage List

Opdivo 10 mg/ml Intravenous Injection
NDC: 0003-3734
Labeler:
E.r. Squibb & Sons, L.L.C.
Opdivo 10 mg/ml Intravenous Injection
NDC: 0003-3756
Labeler:
E.r. Squibb & Sons, L.L.C.
Opdivo 10 mg/ml Intravenous Injection
NDC: 0003-3772
Labeler:
E.r. Squibb & Sons, L.L.C.
Opdivo 10 mg/ml Intravenous Injection
NDC: 0003-3774
Labeler:
E.r. Squibb & Sons, L.L.C.

Popular Topics

Opdivo (nivolumab) reviews

I had stage 3b subungual melanoma and after they did an amputation of my thumb and lymph nodes dissection, they lowered ...

4 REPLIES